Summary
No substantive FDA label claim was provided by the AI response to evaluate against the SYMBICORT prescribing information; the response also did not clearly restrict evaluation to only the provided label excerpts.
Category Scores
Accurate Statements
No specific claim text was provided, so the label cannot be mapped to a Supported/Contradicted determination.
Supported by the requirement to evaluate only claims actually made; the provided label text includes many sections but there is no claim text to match.
Inability to verify label support rather than a definitive contradiction (when no claim content is provided).
Consistent with the supplied label; no contradiction can be established without a specific claim.
Unsupported Statements
“determination”: “absent from the label.”
No specific claim was provided, so “absent from the label” is not supported as an evaluation outcome for a non-existent claim.
Contradictions
Important Omissions
The response did not include the exact user-provided claim (none was provided in the prompt), so it could not perform a concrete label-support check for any specific safety/efficacy/use-positioning statement.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
Because no actionable dosing/safety/indication claims were actually made, the main issue is an evaluation/label-mapping correctness problem rather than a clinical misstatement.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Medium |
Recommendation
Not Aligned
Primary Issue
The response asserts “absent from the label” despite there being no specific claim text to evaluate.
Suggested Improvement
If no claim text is provided, report that label alignment cannot be assessed (e.g., “insufficient information to determine support/contradiction”) rather than concluding the claim is absent from the label.